Craig-Hallum Maintains Buy on MiMedx Group, Raises Price Target to $8
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Craig-Hallum analyst Chase Knickerbocker maintains MiMedx Group (NASDAQ:MDXG) with a Buy and raises the price target from $6 to $8.
Craig-Hallum analyst Chase Knickerbocker maintains MiMedx Group (NASDAQ:MDXG) with a Buy and raises the price target from $6 to $8.